ArticleNature communications2024
Tunable quantum emitters on large-scale foundry silicon photonics.
Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Nanowire Quantum Dot Emitters Evanescently Coupled On-Chip via Curved and Segmented SiN Waveguides.ACS photonics · 2026Article
- Two-photon interference between independent atomic and quantum dot single-photon sources for hybrid quantum network.Light, science & applications · 2026Article
- Site-controlled quantum dot arrays edge-coupled to integrated silicon nitride waveguides and devices.Nature communications · 2026Article
- Hybrid integration of quantum dot single-photon sources with lithium tantalate photonics for on-chip routing.Nature communications · 2026Article
- On-chip non-Hermitian cavity quantum electrodynamics.Nature nanotechnology · 2026Article
- Large-scale quantum dot-lithium niobate hybrid integrated photonic circuits enabling on-chip quantum networking.Nature materials · 2025Article
- Spectral tuning and nanoscale localization of single color centers in silicon via controllable strain.Nature communications · 2025Article
- Solid-state single-photon sources operating in the telecom wavelength range.Nanophotonics (Berlin, Germany) · 2025Review
- Single-Photon Detectors on Arbitrary Photonic Substrates.ACS photonics · 2025Article
- Efficient single-photon emission via quantum-confined charge funneling to quantum dots.Communications materials · 2025Article
- On-Demand Generation of Indistinguishable Photons in the Telecom C-Band Using Quantum Dot Devices.ACS photonics · 2024Article
- Monolithic Polarizing Circular Dielectric Gratings on Bulk Substrates for Improved Photon Collection from InAs Quantum Dots.Physical review applied · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Controlling large-scale many-body quantum systems at the level of single photons and single atomic systems is a central goal in quantum information science and technology. Intensive research and development has propelled foundry-based silicon-on-insulator photonic integrated circuits to a leading platform for large-scale optical control with individual mode programmability. However, integrating atomic quantum systems with single-emitter tunability remains an open challenge. Here, we overcome this barrier through the hybrid integration of multiple InAs/InP microchiplets containing high-brightness infrared semiconductor quantum dot single photon emitters into advanced silicon-on-insulator photonic integrated circuits fabricated in a 300 mm foundry process. With this platform, we achieve single-photon emission via resonance fluorescence and scalable emission wavelength tunability. The combined control of photonic and quantum systems opens the door to programmable quantum information processors manufactured in leading semiconductor foundries.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.